Ronald Myint is an expert in the field of Oncology. He researched medicine at Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine Ronald Myint is also a published MD. He has 1 paper published. The most recent paper is: Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. He is registered with Medicare.
NPI NUMBER | 1003076795 | |
NPPES Provider LastName | MYINT | |
NPPES Provider FirstName | RONALD | |
NPPES Provider ZIPCode | 604532654 | |
NPPES Provider State | IL | |
Specialty Description | Internal Medicine | |
Total Claim Count | 39.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1003076795 |
Last Name Of The Provider | MYINT |
First Name Of The Provider | RONALD |
View All |
![]() |
Dr. Gary A. Steinecker, MD
![]() ![]() |
![]() |
Dr. Jayanthi R. Ramadurai, MD
![]() |
![]() |
Dr. Rajalaxmi S. McKenna, MD
![]() |
![]() |
Dr. Raj R. Mittal, MD
![]() |
![]() |
Dr. Amber D. Seba, MD
![]() |